| Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial DJ Hausenloy, RK Kharbanda, UK Møller, M Ramlall, J Aarøe, R Butler, ... The Lancet 394 (10207), 1415-1424, 2019 | 310 | 2019 |
| Adherence to the ‘atrial fibrillation better care’pathway in patients with atrial fibrillation: impact on clinical outcomes—a systematic review and meta-analysis of 285,000 … GF Romiti, D Pastori, JM Rivera-Caravaca, WY Ding, YX Gue, ... Thrombosis and haemostasis 122 (03), 406-414, 2022 | 308 | 2022 |
| Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double … JP Piccini, V Caso, SJ Connolly, KAA Fox, J Oldgren, WS Jones, ... The lancet 399 (10333), 1383-1390, 2022 | 176 | 2022 |
| Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review WJ Jenner, R Kanji, S Mirsadraee, YX Gue, S Price, S Prasad, DA Gorog Journal of thrombosis and thrombolysis 51, 595-607, 2021 | 94 | 2021 |
| Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent … M Farag, N Spinthakis, YX Gue, M Srinivasan, K Sullivan, D Wellsted, ... European heart journal 40 (3), 295-305, 2019 | 76 | 2019 |
| Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-Pacific expert consensus paper DA Gorog, YX Gue, TF Chao, L Fauchier, JL Ferreiro, K Huber, ... Thrombosis and Haemostasis 122 (10), 1625-1652, 2022 | 48 | 2022 |
| Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19 YX Gue, M Tennyson, J Gao, S Ren, R Kanji, DA Gorog Scientific reports 10 (1), 21379, 2020 | 37 | 2020 |
| MINOCA presenting with STEMI: incidence, aetiology and outcome in a contemporaneous cohort YX Gue, N Corballis, A Ryding, JC Kaski, DA Gorog Journal of thrombosis and thrombolysis 48, 533-538, 2019 | 29 | 2019 |
| Reduction in ACE2 may mediate the prothrombotic phenotype in COVID-19 YX Gue, DA Gorog European Heart Journal 41 (33), 3198-3199, 2020 | 28 | 2020 |
| Out-of-hospital cardiac arrest: A systematic review of current risk scores to predict survival K ADATIA, R KANJI, T POTPARA, YH Gregory, DA GOROG American heart journal 234, 31-41, 2021 | 26 | 2021 |
| Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation N Spinthakis, Y Gue, M Farag, M Srinivasan, D Wellsted, ... EP Europace 21 (9), 1297-1306, 2019 | 26 | 2019 |
| MI with non-obstructive coronary artery presenting with STEMI: a review of incidence, aetiology, assessment and treatment YX Gue, R Kanji, S Gati, DA Gorog European Cardiology Review 15, 2020 | 23 | 2020 |
| Importance of endogenous fibrinolysis in platelet thrombus formation YX Gue, DA Gorog International journal of molecular sciences 18 (9), 1850, 2017 | 22 | 2017 |
| Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with … DA Gorog, YX Gue, TF Chao, L Fauchier, JL Ferreiro, K Huber, ... Europace 24 (11), 1844-1871, 2022 | 21 | 2022 |
| Imbalance between fibrin clot formation and fibrinolysis predicts cardiovascular events in patients with stable coronary artery disease S Neergaard-Petersen, SB Larsen, EL Grove, SD Kristensen, RA Ajjan, ... Thrombosis and haemostasis 120 (01), 075-082, 2020 | 21 | 2020 |
| Effect of P2Y12 inhibitors on thrombus stability and endogenous fibrinolysis N Spinthakis, M Farag, YX Gue, M Srinivasan, DM Wellsted, DA Gorog Thrombosis research 173, 102-108, 2019 | 18 | 2019 |
| Usefulness of the NULL-PLEASE score to predict survival in out-of-hospital cardiac arrest YX Gue, M Sayers, BT Whitby, R Kanji, K Adatia, R Smith, WR Davies, ... The American Journal of Medicine 133 (11), 1328-1335, 2020 | 17 | 2020 |
| Relationship of platelet reactivity and inflammatory markers to recurrent adverse events in patients with ST-elevation myocardial infarction K Adatia, MF Farag, YX Gue, M Srinivasan, DA Gorog Thrombosis and haemostasis 119 (11), 1785-1794, 2019 | 17 | 2019 |
| Stroke prevention in atrial fibrillation GYH Lip, Y Gue, J Zhang, TF Chao, H Calkins, T Potpara Trends in cardiovascular medicine 32 (8), 501-510, 2022 | 11 | 2022 |
| Impact of preadmission morphine on reinfarction in patients with ST‐elevation myocardial infarction treated with percutaneous coronary intervention: a meta‐analysis YX Gue, N Spinthakis, M Farag, J Kubica, JM Siller‐Matula, M Srinivasan, ... Clinical Pharmacology & Therapeutics 108 (1), 54-62, 2020 | 11 | 2020 |
